SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001116502-05-001465
Filing Date
2005-06-27
Accepted
2005-06-27 15:00:36
Documents
1
Period of Report
2005-06-27

Document Format Files

Seq Description Document Type Size
1 debroff-lawrence_ex.html 4/A  
1 debroff-lawrence_ex.xml 4/A 2983
  Complete submission text file 0001116502-05-001465.txt   4740
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 SOUTHWICK COURT NORTH PLAINVIEW NY 11803
Business Address 516-428-8575
Dobroff Lawrence (Reporting) CIK: 0001311547 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-19879 | Film No.: 05917273